Watling KJ - Search Results

1

The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.

Guard S, Boyle SJ, Tang KW, Watling KJ, McKnight AT, Woodruff GN. Guard S, et al. Among authors: watling kj. Br J Pharmacol. 1993 Sep;110(1):385-91. doi: 10.1111/j.1476-5381.1993.tb13821.x. Br J Pharmacol. 1993. PMID: 7693284 Free PMC article.

2

Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.

Suman-Chauhan N, Grimson P, Guard S, Madden Z, Chung FZ, Watling K, Pinnock R, Woodruff G. Suman-Chauhan N, et al. Eur J Pharmacol. 1994 Sep 15;269(1):65-72. doi: 10.1016/0922-4106(94)90027-2. Eur J Pharmacol. 1994. PMID: 7530207

3

Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.

Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ. Fan TP, et al. Among authors: watling kj. Br J Pharmacol. 1993 Sep;110(1):43-9. doi: 10.1111/j.1476-5381.1993.tb13769.x. Br J Pharmacol. 1993. PMID: 7693287 Free PMC article.

4

Structure-activity requirements of bombesin for gastrin-releasing peptide- and neuromedin B-preferring bombesin receptors in rat brain.

Guard S, Watling KJ, Howson W. Guard S, et al. Among authors: watling kj. Eur J Pharmacol. 1993 Aug 24;240(2-3):177-84. doi: 10.1016/0014-2999(93)90896-p. Eur J Pharmacol. 1993. PMID: 8243536

5

[125I]neurokinin A labels pharmacologically distinct populations of NK2 binding sites in hamster and rabbit urinary bladder.

Guard S, Pain D, Franks R, Watling KJ. Guard S, et al. Among authors: watling kj. Eur J Pharmacol. 1993 Mar 2;232(2-3):287-90. doi: 10.1016/0014-2999(93)90786-h. Eur J Pharmacol. 1993. PMID: 8385619

6

Pharmacological characterization of tachykinin-stimulated inositol phospholipid hydrolysis in peripheral tissues.

Suman-Chauhan N, Guard S, Williams BJ, Watling KJ. Suman-Chauhan N, et al. Among authors: watling kj. Br J Pharmacol. 1990 Dec;101(4):1001-5. doi: 10.1111/j.1476-5381.1990.tb14196.x. Br J Pharmacol. 1990. PMID: 1707702 Free PMC article.

7

Rational design of high affinity tachykinin NK2 receptor antagonists.

Boyle S, Guard S, Hodgson J, Horwell DC, Howson W, Hughes J, McKnight A, Martin K, Pritchard MC, Watling KJ, et al. Boyle S, et al. Among authors: watling kj. Bioorg Med Chem. 1994 Feb;2(2):101-13. doi: 10.1016/s0968-0896(00)82006-4. Bioorg Med Chem. 1994. PMID: 7922121

8

The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors.

Chung FZ, Wu LH, Vartanian MA, Watling KJ, Guard S, Woodruff GN, Oxender DL. Chung FZ, et al. Among authors: watling kj. Biochem Biophys Res Commun. 1994 Feb 15;198(3):967-72. doi: 10.1006/bbrc.1994.1138. Biochem Biophys Res Commun. 1994. PMID: 8117304

9

Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.

Guard S, Watson SP, Maggio JE, Too HP, Watling KJ. Guard S, et al. Among authors: watling kj. Br J Pharmacol. 1990 Apr;99(4):767-73. doi: 10.1111/j.1476-5381.1990.tb13004.x. Br J Pharmacol. 1990. PMID: 1694464 Free PMC article.

10

Neurokinin3-receptors are linked to inositol phospholipid hydrolysis in the guinea-pig ileum longitudinal muscle-myenteric plexus preparation.

Guard S, Watling KJ, Watson SP. Guard S, et al. Among authors: watling kj. Br J Pharmacol. 1988 May;94(1):148-54. doi: 10.1111/j.1476-5381.1988.tb11509.x. Br J Pharmacol. 1988. PMID: 2456806 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters